Maximilian Stahl, MD
Dana-Farber Cancer Institute
Dr. Stahl is a member of the Adult Leukemia Group at Dana-Farber Cancer Institute and an Instructor of Medicine at Harvard Medical School. His research focus is on early phase clinical trials in myeloid malignancies including acute myeloid leukemia and myelodysplastic syndromes. He authored and co-authored more than 70 peer reviewed publications and has presented his research in multiple national and international meetings. He received the ASCO Conquer Cancer Foundation Young Investigator Award, the ASH HONORS Award and several abstract achievement awards. He is a member of the Editorial Board of Leukemia & Lymphoma and serves as a reviewer for several journals including Blood, Blood Advances and Clinical Cancer Research. He graduated from Hannover Medical School in Germany and completed his internal medicine residency and chief residency at Yale School of Medicine and his Hematology and Oncology fellowship at Memorial Sloan Kettering Cancer Center.